within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H02B_CorticosteroidsForSystemicUseCombinations.H02BX01_MethylprednisoloneCombinations;

model MethylprednisoloneCombinations
  extends Pharmacolibrary.Drugs.ATC.H.H02BX01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H02BX01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Methylprednisolone is a synthetic corticosteroid drug used for its potent anti-inflammatory and immunosuppressive effects. It is commonly utilized to treat a wide range of conditions, including severe allergies, asthma, autoimmune diseases, and in combination regimens for specific indications like rheumatologic disorders. Combinations may include additional agents for synergistic effects. Methylprednisolone and its combinations are approved and widely used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult receiving methylprednisolone combination therapy, as specific combination data could not be identified in published literature. Estimates are derived from general methylprednisolone PK data.</p><h4>References</h4><ol><li><p>Hazra, A, et al., &amp; Jusko, WJ (2007). Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats. <i>Biopharmaceutics &amp; drug disposition</i> 28(6) 263–273. DOI:<a href=&quot;https://doi.org/10.1002/bdd.551&quot;>10.1002/bdd.551</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17569107/&quot;>https://pubmed.ncbi.nlm.nih.gov/17569107</a></p></li><li><p>Slayter, KL, et al., &amp; Jusko, WJ (1996). Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics. <i>Clinical pharmacology and therapeutics</i> 59(3) 312–321. DOI:<a href=&quot;https://doi.org/10.1016/S0009-9236(96)80009-9&quot;>10.1016/S0009-9236(96)80009-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8653994/&quot;>https://pubmed.ncbi.nlm.nih.gov/8653994</a></p></li><li><p>Salt, AN, &amp; Plontke, SK (2020). Steroid Nomenclature in Inner Ear Therapy. <i>Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology</i> 41(6) 722–726. DOI:<a href=&quot;https://doi.org/10.1097/MAO.0000000000002624&quot;>10.1097/MAO.0000000000002624</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32195918/&quot;>https://pubmed.ncbi.nlm.nih.gov/32195918</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end MethylprednisoloneCombinations;
